These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30305309)

  • 1. Addressing Financial Disincentives to Improve CKD Care.
    Berns JS; Saffer TL; Lin E
    J Am Soc Nephrol; 2018 Nov; 29(11):2610-2612. PubMed ID: 30305309
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidisciplinary team care for CKD-MBD. Achieving KDIGO guideline recommendations in the bundling era.
    McCann L; Hoefs M
    Nephrol News Issues; 2014 Apr; 28(4):24-6, 28, 30-2 passim. PubMed ID: 24960985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebasing the Medicare payment for dialysis: rationale, challenges, and opportunities.
    Wish D; Johnson D; Wish J
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2195-202. PubMed ID: 25189926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pay-for-performance for chronic kidney disease patients on hemodialysis: a systematic review protocol.
    Otts JAA; Pearce PF; Langford CA
    JBI Database System Rev Implement Rep; 2017 Jul; 15(7):1850-1855. PubMed ID: 28708749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiments in payment.
    Taylor M
    Hosp Health Netw; 2008 Sep; 82(9):28-33, 1. PubMed ID: 18841682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Savings Opportunity from Improved CKD Care Management.
    Liu HH; Zhao S
    J Am Soc Nephrol; 2018 Nov; 29(11):2612-2615. PubMed ID: 30279275
    [No Abstract]   [Full Text] [Related]  

  • 7. Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.
    Mukhopadhyay P; Pearson J; Cogan C; Gaber C; Gillespie BW; Turenne M
    Med Care; 2019 Aug; 57(8):584-591. PubMed ID: 31295188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare Reform: Payment Reform.
    Thomson Reuters Accelus.
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-42. PubMed ID: 29360300
    [No Abstract]   [Full Text] [Related]  

  • 9. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
    Hidai H
    Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New ESRD clinical performance measures and data collection system: progress and pitfalls.
    Wish JB
    Nephrol News Issues; 2008 Jul; 22(8):12-3. PubMed ID: 18711877
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicare program; end-stage renal disease quality incentive program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Jan; 76(3):627-46. PubMed ID: 21261127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.
    Reilly R; Evans K; Gomersall J; Gorham G; Peters MD; Warren S; O'Shea R; Cass A; Brown A
    BMC Health Serv Res; 2016 Apr; 16():119. PubMed ID: 27048280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing key cost drivers associated with caring for chronic kidney disease patients.
    Damien P; Lanham HJ; Parthasarathy M; Shah NL
    BMC Health Serv Res; 2016 Dec; 16(1):690. PubMed ID: 28031020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving health care through an economic approach to health care management.
    Tabbush V
    Clin Obstet Gynecol; 1994 Mar; 37(1):216-34. PubMed ID: 8194211
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic incentives and barriers to quality care.
    Coutts LR
    Nephrol News Issues; 2007 May; 21(6):5. PubMed ID: 17518116
    [No Abstract]   [Full Text] [Related]  

  • 16. Using knowledge of multiple levels of variation in care to target performance incentives to providers.
    Turenne MN; Hirth RA; Pan Q; Wolfe RA; Messana JM; Wheeler JR
    Med Care; 2008 Feb; 46(2):120-6. PubMed ID: 18219239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Payment Models and Opportunities to Address Disparities in Kidney Disease.
    Tummalapalli SL; Ibrahim SA
    Am J Kidney Dis; 2021 May; 77(5):769-772. PubMed ID: 33098924
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will payment and quality-driven reform improve outcomes?
    Neumann ME
    Nephrol News Issues; 2012 Oct; 26(11):12. PubMed ID: 23427715
    [No Abstract]   [Full Text] [Related]  

  • 20. In a bundling era, finding a fair price for ESRD services.
    Sullivan JD
    Nephrol News Issues; 2007 Mar; 21(4):37, 39-40. PubMed ID: 17393926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.